DK1146865T3 - Farmaceutisk præparat omfattende en kombination af dextro- og laevoisomerer af sotalol - Google Patents

Farmaceutisk præparat omfattende en kombination af dextro- og laevoisomerer af sotalol

Info

Publication number
DK1146865T3
DK1146865T3 DK99902781T DK99902781T DK1146865T3 DK 1146865 T3 DK1146865 T3 DK 1146865T3 DK 99902781 T DK99902781 T DK 99902781T DK 99902781 T DK99902781 T DK 99902781T DK 1146865 T3 DK1146865 T3 DK 1146865T3
Authority
DK
Denmark
Prior art keywords
sotalol
dextro
combination
isomers
antiarrhythmic
Prior art date
Application number
DK99902781T
Other languages
Danish (da)
English (en)
Inventor
Alangudi Sankaranarayanan
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK1146865T3 publication Critical patent/DK1146865T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
DK99902781T 1999-02-05 1999-02-22 Farmaceutisk præparat omfattende en kombination af dextro- og laevoisomerer af sotalol DK1146865T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN89KO1999 IN188162B (pt) 1999-02-05 1999-02-05
PCT/IB1999/000322 WO2000045807A1 (en) 1999-02-05 1999-02-22 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol

Publications (1)

Publication Number Publication Date
DK1146865T3 true DK1146865T3 (da) 2003-09-22

Family

ID=38668683

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99902781T DK1146865T3 (da) 1999-02-05 1999-02-22 Farmaceutisk præparat omfattende en kombination af dextro- og laevoisomerer af sotalol

Country Status (20)

Country Link
US (1) US6281246B2 (pt)
EP (1) EP1146865B9 (pt)
JP (1) JP2002536324A (pt)
CN (1) CN1149987C (pt)
AT (1) ATE241349T1 (pt)
AU (1) AU761521C (pt)
BR (1) BR9915951A (pt)
CA (1) CA2348882C (pt)
CZ (1) CZ20011807A3 (pt)
DE (1) DE69908421T2 (pt)
DK (1) DK1146865T3 (pt)
ES (1) ES2195538T3 (pt)
HK (1) HK1041206B (pt)
HU (1) HU224033B1 (pt)
IN (1) IN188162B (pt)
PL (1) PL351143A1 (pt)
PT (1) PT1146865E (pt)
RU (1) RU2213560C2 (pt)
SE (1) SE1146865T5 (pt)
WO (1) WO2000045807A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060105044A1 (en) 2004-05-20 2006-05-18 Singh Bramah N Sustained release formulations of sotalol
CN101448784B (zh) * 2006-05-18 2012-07-04 冬姆佩股份公司 (2r)-2-[(4-磺酰基)氨基苯基]丙酰胺及含有它们的药物组合物
CN102329254B (zh) * 2010-07-12 2014-02-05 上海奥博生物医药技术有限公司 一种制备n-[4-[1-羟基-2-[(1-甲基乙基)胺基]乙基]甲磺酰胺盐酸盐的方法
BE1021328B1 (fr) * 2014-08-27 2015-10-30 Hyloris Pharmaceuticals SA Composition pharmaceutique prete a l'emploi
BE1021320B1 (fr) * 2014-08-27 2015-10-29 Hyloris Pharmaceuticals SA Composition pharmaceutique prete a l'emploi
FR3050297A1 (fr) * 2016-04-13 2017-10-20 Assist Publique - Hopitaux De Paris Methode de determination de la susceptibilite d'induction d'une torsade de pointes
CN109419779B (zh) * 2017-09-04 2021-05-25 鲁南制药集团股份有限公司 一种盐酸索他洛尔制剂
CN109419780B (zh) * 2017-09-04 2021-05-11 张家港市中医医院 一种盐酸索他洛尔片剂及其制备方法
CN108785268B (zh) * 2018-01-17 2021-05-28 威海华新药业集团有限公司 一种盐酸索他洛尔制剂及其制备方法
US10799138B2 (en) 2018-04-05 2020-10-13 University Of Maryland, Baltimore Method of administering sotalol IV/switch
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089526A (en) * 1983-05-23 1992-02-18 Bristol-Myers Company Antiarrhythmic class III process
JPH01165569A (ja) * 1987-12-22 1989-06-29 Mitsui Toatsu Chem Inc 光学活性なソタロールの製造方法
IES940272A2 (en) * 1994-02-17 1994-11-16 Russinsky Ltd "Pharmaceutical Products"

Also Published As

Publication number Publication date
CN1328453A (zh) 2001-12-26
EP1146865B1 (en) 2003-05-28
PL351143A1 (en) 2003-03-24
HUP0104175A3 (en) 2002-12-28
JP2002536324A (ja) 2002-10-29
ATE241349T1 (de) 2003-06-15
HK1041206B (zh) 2003-10-31
US6281246B2 (en) 2001-08-28
CA2348882A1 (en) 2000-08-10
AU761521B2 (en) 2003-06-05
CA2348882C (en) 2004-07-13
US20010004643A1 (en) 2001-06-21
EP1146865B9 (en) 2004-03-17
AU761521C (en) 2004-01-22
CZ20011807A3 (cs) 2001-08-15
SE1146865T5 (pt) 2003-11-18
BR9915951A (pt) 2001-08-21
DE69908421D1 (de) 2003-07-03
HUP0104175A2 (hu) 2002-04-29
WO2000045807A1 (en) 2000-08-10
IN188162B (pt) 2002-08-31
PT1146865E (pt) 2003-08-29
AU2296099A (en) 2000-08-25
EP1146865A1 (en) 2001-10-24
HK1041206A1 (en) 2002-07-05
SE1146865T3 (pt) 2003-09-02
ES2195538T3 (es) 2003-12-01
DE69908421T2 (de) 2004-03-18
HU224033B1 (hu) 2005-05-30
CN1149987C (zh) 2004-05-19
RU2213560C2 (ru) 2003-10-10

Similar Documents

Publication Publication Date Title
DK1146865T3 (da) Farmaceutisk præparat omfattende en kombination af dextro- og laevoisomerer af sotalol
BR0108584A (pt) Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva
ES8505519A1 (es) Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos.
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
FI925342A0 (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
BR0113331A (pt) Derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica
ES2197792A1 (es) Formulaciones farmaceuticas y metodos que contienen morfina intranasal.
BR0014378A (pt) Derivados de ácido indolil-3-glioxìlico tendo propriedades terapeuticamente valiosas
ATE360419T1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
RU2000126790A (ru) Композиция, предназначенная для лечения алкогольной и лекарственной зависимости, содержащая опиоидный антагонист и модулятор nmda рецепторного комплекса
BR0012951A (pt) Agonistas de retinóides seletivos
RU2002105377A (ru) Ксенон-антагонист nmda
BG105691A (en) Tumor necrosis factor antagonists and their use in endometriosis
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
Narita et al. Antagonism of the morphine-induced Straub tail reaction by κ-opioid receptor activation in mice
PT1058544E (pt) Inibicao da actividade do tnf
BRPI0307319B8 (pt) forma de dosagem oral para liberação controlada de droga e processo para sua preparação
Chipkin et al. Determination of analgesic drug efficacies by modification of the Randall and Selitto rat yeast paw test
GEP20043252B (en) Use of NOS Inhibitors by New Pharmaceutical Designation for Treatment of Chronic and Acute Pains with Mammalians
KANETO et al. Morphine analgesia without development of tolerance in reserpinized mice
BR9611671A (pt) Método de alvejamento de dosagens de medicamentos e de agentes terapêuticos e de outros glicosaminoglicanos (gags) para tratar de uma doença ou condição em um ser humano.
BR0009289A (pt) Uso de inibidores da vasopeptidase para tratar angina pectoris
BR9916434A (pt) Uso de um antagonista de receptor 5hr2a e 5ht2a/c para preparação de medicamentos para tratamento de ronco e sìndrome de resistência elevada das vias aéreas superiores